BIOMAT Database Logo BIOMAT Database Logo

Characterization of a 105-kDa polypeptide encoded in gene 1 of the human coronavirus HCV 229E. 1996

C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Department of Viral Zoonoses, Federal Institute for Health Protection of Consumers and Veterinary Medicine, Berlin, Germany.

Gene 1 of the human coronavirus HCV 229E encompasses approximately 20.7 kb and contains two overlapping open reading frames, ORF 1a and ORF 1b. The downstream ORF 1b is expressed by a mechanism involving (-1) ribosomal frameshifting. Translation of mRNA 1, which is thought to be equivalent to the viral genomic RNA, results in the synthesis of two large polyproteins, pp1a and pp1ab. These polyproteins contain motifs characteristic of papain-like and 3C-like proteinases, RNA-dependent RNA polymerases, helicases, and metal-binding proteins. In this study, we have produced pp1ab-specific monoclonal antibodies and have used them to detect an intracellular, 105-kDa viral polypeptide that contains the putative RNA polymerase domain. Furthermore, using trans cleavage assays with bacterially expressed HCV 229E 3C-like proteinase, we have demonstrated that the 105-kDa polypeptide is released from pp1ab by cleavage at the dipeptide bonds Gln-4068/Ser-4069 and Gln-4995/Ala-4996. These data contribute to the characterization of coronavirus 3C-like proteinase-mediated processing of pp1ab and provide the first identification of an HCV 229E ORF 1ab-encoded polypeptide in virus-infected cells.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D005260 Female Females
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086042 3C Viral Proteases A class of cysteine proteases which play an essential role in VIRUS REPLICATION. They cleave precursor viral POLYPROTEINS to produce functional proteins and enzymes. In addition, they cleave certain host cell proteins such as EUKARYOTIC INITIATION FACTOR-4G. 3C Proteases,3C Proteinases,3C-like Viral Proteases,3Cpro Proteinases,Proteases, 3C,Proteases, 3C-like Viral,Proteinases, 3C,Viral Proteases, 3C-like

Related Publications

C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Characterization of the human coronavirus 229E (HCV 229E) gene 1.
January 1993, Advances in experimental medicine and biology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Characterization of a papain-like cysteine-proteinase encoded by gene 1 of the human coronavirus HCV 229E.
January 1998, Advances in experimental medicine and biology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Identification of an ATPase activity associated with a 71-kilodalton polypeptide encoded in gene 1 of the human coronavirus 229E.
July 1997, Journal of virology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Characterization of functional domains in the human coronavirus HCV 229E receptor.
October 1996, The Journal of general virology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Nucleotide sequence of the gene encoding the spike glycoprotein of human coronavirus HCV 229E.
May 1990, The Journal of general virology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Molecular characterization of the 229E strain of human coronavirus.
January 1990, Advances in experimental medicine and biology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate.
February 1998, Journal of virology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity.
July 1995, Journal of virology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Neurotropism of human coronavirus 229E.
January 1993, Advances in experimental medicine and biology,
C Grötzinger, and G Heusipp, and J Ziebuhr, and U Harms, and J Süss, and S G Siddell
Characterization of human T cell clones specific for coronavirus 229E.
January 1995, Advances in experimental medicine and biology,
Copied contents to your clipboard!